383 related articles for article (PubMed ID: 22147145)
1. Disparities in blood pressure control within a community-based provider network: an exploratory analysis.
Romanelli RJ; Schiro TA; Jukes T; Wong KS; Ishisaka DY
Ann Pharmacother; 2011 Dec; 45(12):1473-82. PubMed ID: 22147145
[TBL] [Abstract][Full Text] [Related]
2. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network.
Ishisaka DY; Jukes T; Romanelli RJ; Wong KS; Schiro TA
J Am Soc Hypertens; 2012; 6(3):201-9. PubMed ID: 22520931
[TBL] [Abstract][Full Text] [Related]
3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
4. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
Gu Q; Burt VL; Paulose-Ram R; Dillon CF
Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive medication use among US adults with hypertension.
Gu Q; Paulose-Ram R; Dillon C; Burt V
Circulation; 2006 Jan; 113(2):213-21. PubMed ID: 16391156
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis].
Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
Nihon Jinzo Gakkai Shi; 2005; 47(1):38-45. PubMed ID: 15754762
[TBL] [Abstract][Full Text] [Related]
12. The effect of age on hypertension control and management.
Borzecki AM; Glickman ME; Kader B; Berlowitz DR
Am J Hypertens; 2006 May; 19(5):520-7. PubMed ID: 16647627
[TBL] [Abstract][Full Text] [Related]
13. The association between hypertension-specific care management processes and blood pressure outcomes in US-based physician organizations.
Wong K; Smalarz A; Wu N; Boulanger L; Wogen J
J Am Soc Hypertens; 2011; 5(6):505-12. PubMed ID: 21958468
[TBL] [Abstract][Full Text] [Related]
14. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
[TBL] [Abstract][Full Text] [Related]
15. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
16. Treatment of 5413 hypertensive patients: a cross-sectional study.
Paulsen MS; Sondergaard J; Reuther L; Larsen PS; Munck AP; Larsen PV; Damsgaard J; Poulsen L; Hansen DG; Jacobsen IA; Larsen ML; Christensen HR; Christensen B; Andersen M
Fam Pract; 2011 Dec; 28(6):599-607. PubMed ID: 21596691
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
18. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
19. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics.
Duggirala MK; Cuddihy RM; Cuddihy MT; Naessens JM; Cha SS; Mandrekar JN; Leibson CL
Am J Hypertens; 2005 Jun; 18(6):833-8. PubMed ID: 15925744
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.
Thoenes M; Neuberger HR; Volpe M; Khan BV; Kirch W; Böhm M
J Hum Hypertens; 2010 May; 24(5):336-44. PubMed ID: 19798089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
